US Biomax는 미국에 본사를 두고 있는 회사로, 다양한Paraffin Tissue Array, Paraffin Tissue Section등 을 제공하고 있습니다.
바이오 클론은 US Biomax의 한국 독점 대리점으로 합리적인 가격으로 제품을 제공하고 있습니다.
www.bioclone.co.kr/usbiomax/
https://www.biomax.us/
Products List
Human Paraffin Embedded Tissue Array : Bladder
Name |
Description |
Cores |
Cases |
BC12011c |
Bladder cancer tissue array, including TNM, 63 cases/63 cores, replaced by BC12011d
|
63 |
63 |
BL1001 |
Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores
|
100 |
25 |
BL1002b |
Bladder cancer and normal tissue array, including pathology grade, TNM and clinical stage, 50 cases/ 100 cores, replacing BL1002a
|
100 |
50 |
BL1501 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, replaced by BL1501a
|
150 |
75 |
BL1501a |
Multiple bladder carcinoma with bladder tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BL1501
|
150 |
75 |
BL1921 |
Mid-advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores
|
192 |
96 |
BL208 |
Bladder cancer with bladder tissue array (2016 WHO classification), including pathology grade, TNM and clinical stage, 69 cases/207 cores
|
207 |
69 |
BL2081b |
High density bladder cancer with bladder tissue array, including pathology grade, TNM and clinical stage, 208 cases/208 cores, replacing BL2081a
|
208 |
208 |
BL2082a |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 208 cases/ 208 cores, replacing BL2082
|
208 |
208 |
BL208a |
Bladder cancer with bladder tissue array (2016 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 64 cases/192 cores, replacing BL208
|
192 |
64 |
BL241a |
Bladder cancer tissue array with matched cancer adjacent tissue, including TNM and pathology grade, 10 cases/24 cores, replaced by BL241b
|
24 |
10 |
BL241b |
Bladder urothelial carcinoma with matched cancer adjacent bladder tissue array, including TNM and clinical stage, 10 cases/24 cores, replacing BL241a
|
24 |
10 |
BL242 |
Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases/48 cores
|
48 |
24 |
BL243 |
Bladder cancer tissue array with normal tissues from autopsy, 12 cases/24 cores with stage and grade data
|
24 |
12 |
BL244a |
Bladder cancer with matched cancer adjacent bladder tissue array, including TNM and clinical stage, 12 cases/24 cores, replacing BL244
|
24 |
12 |
BL481b |
Bladder cancer tissue array with normal bladder tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replaced by BL481c
|
48 |
48 |
BL481c |
Bladder cancer with normal bladder tissue array, including TNM and clinical stage, 48 cases/48 cores, replacing BL481b
|
48 |
48 |
BL601 |
Bladder cancer (stage III-IV) tissue array, including TNM, clinical stage and pathology grade, 60 cases/60 cores
|
60 |
60 |
BL601a |
Bladder cancer (stage III-IV) tissue array, including pathology grade, TNM and clinical stage, 60 cases/60 cores, replacing BL601
|
60 |
60 |
BL631 |
Bladder cancer tissue array with matched adjacent normal bladder tissue, including TNM and pathology grade, 24 cases/63 cores
|
63 |
24 |
BL721 |
Bladder cancer tissue array with normal tissues, 24 cases/72 cores
|
72 |
24 |
BL802b |
Bladder cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing BL802a
|
80 |
80 |
BL803 |
Bladder cancer and normal tissue array with TNM and grade data, 40 cases/80 cores
|
80 |
40 |
BL804 |
Bladder disease spectrum (urocystic cancer progression) with bladder tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores
|
80 |
80 |
BL805 |
Mid-advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases/80 cores, replaced by BL805a
|
80 |
80 |
BL805b |
Mid-advanced stage bladder cancer tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BL805a
|
80 |
80 |
BL806b |
Bladder cancer and bladder tissue array, including pathology grade, TNM and clinical stage, 60 cases/80 cores, replacing BL806a
|
80 |
60 |
BL807 |
Bladder cancer with bladder tissue array, including TNM and clinical stage, 80 cases/80 cores
|
80 |
80 |
BL921 |
Advanced stage multiple bladder cancer (most are stage III) tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 92 cases/92 cores
|
92 |
92 |
BLC1501 |
Bladder cancer mid-density tissue array, 75 cases/150 cores
|
150 |
75 |
BLC241 |
Bladder cancer tissue array, 12 cases/24 cores
|
24 |
12 |
BLC661 |
Bladder cancer with adjacent normal bladder tissue array, including pathology grade, TNM and clinical stage, 33 cases/66 cores
|
66 |
33 |
BNC12011 |
Normal bladder tissue array, including TNM, clinical stage and pathology grade, 40 cases/ 80 cores
|
80 |
40 |
HBla-Uro105Sur-01 |
Bladder cancer tissue array, 59 cases. 46 cases have tumor and matched normal adjacent tissue (NAT)
|
105 |
59 |
HBlaU066Su01 |
Bladder carcinoma tissue microarray (56 cases) and normal adjacent tissue. With survival data. Replaces HBla-Uro105Sur-01
|
66 |
56 |
OD-CT-UrBla03-003 |
Human bladder carcinoma tissue array, cervix carcinoma, invasive edge tissue and normal adjacent tissue, 22 cases
|
58 |
22 |
T121b |
Bladder cancer with bladder tissue test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T121a
|
24 |
6 |
T124c |
Bladder cancer with bladder tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T124b
|
24 |
12 |
Homepage : www.bioclone.co.kr
한국독점대리점 바이오클론㈜
T) 02-2690-0058 F) 02-2690-0397
www.bioclone.co.kr
Homepage : www.bioclone.co.kr
|
|